BrainStorm Cell Therapeutics to Announce Second Quarter Financial Results and Provide a Corporate and R&D Update
- Monday, July 27, 2020, 7:12
- PR Newswire
- Add a comment
NEW YORK, July 27, 2020 /PRNewswire/ — BrainStorm-Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, announced today that the Company will hold a conference call to update shareholders…
About the Author
admin has written 20736 stories on this site.